Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats

Nephrotoxicity is one of the limiting factors for using doxorubicin (DOX). Interleukin 1 has major role in DOX-induced nephrotoxicity, so we investigated the effect of interleukin 1 receptor antagonist diacerein (DIA) on DOX-induced nephrotoxicity. DIA (25 and 50 mg/kg/day) was administered orally t...

Full description

Saved in:
Bibliographic Details
Main Authors: Marwa M. M. Refaie, Entesar F. Amin, Nashwa F. El-Tahawy, Aly M. Abdelrahman
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Toxicology
Online Access:http://dx.doi.org/10.1155/2016/9507563
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552431200763904
author Marwa M. M. Refaie
Entesar F. Amin
Nashwa F. El-Tahawy
Aly M. Abdelrahman
author_facet Marwa M. M. Refaie
Entesar F. Amin
Nashwa F. El-Tahawy
Aly M. Abdelrahman
author_sort Marwa M. M. Refaie
collection DOAJ
description Nephrotoxicity is one of the limiting factors for using doxorubicin (DOX). Interleukin 1 has major role in DOX-induced nephrotoxicity, so we investigated the effect of interleukin 1 receptor antagonist diacerein (DIA) on DOX-induced nephrotoxicity. DIA (25 and 50 mg/kg/day) was administered orally to rats for 15 days, in the presence or absence of nephrotoxicity induced by a single intraperitoneal injection of DOX (15 mg/kg) at the 11th day. We measured levels of serum urea, creatinine, renal reduced glutathione (GSH), malondialdehyde (MDA), total nitrites (NOx), catalase, and superoxide dismutase (SOD). In addition, caspase-3, tumor necrosis factor alpha (TNFα), nuclear factor kappa B (NFκB) expressions, and renal histopathology were assessed. Our results showed that DOX-induced nephrotoxicity was ameliorated or reduced by both doses of DIA, but diacerein high dose (DHD) showed more improvement than diacerein low dose (DLD). This protective effect was manifested by significant improvement in all measured parameters compared to DOX treated group by using DHD. DLD showed significant improvement of creatinine, MDA, NOx, GSH, histopathology, and immunohistochemical parameters compared to DOX treated group.
format Article
id doaj-art-5633e87007d44a718120f7d29ea1d516
institution Kabale University
issn 1687-8191
1687-8205
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Toxicology
spelling doaj-art-5633e87007d44a718120f7d29ea1d5162025-02-03T05:58:40ZengWileyJournal of Toxicology1687-81911687-82052016-01-01201610.1155/2016/95075639507563Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in RatsMarwa M. M. Refaie0Entesar F. Amin1Nashwa F. El-Tahawy2Aly M. Abdelrahman3Department of Pharmacology, Faculty of Medicine, El-Minia University, El-Minia 61111, EgyptDepartment of Pharmacology, Faculty of Medicine, El-Minia University, El-Minia 61111, EgyptDepartment of Histology, Faculty of Medicine, El-Minia University, El-Minia 61111, EgyptDepartment of Pharmacology, Faculty of Medicine, El-Minia University, El-Minia 61111, EgyptNephrotoxicity is one of the limiting factors for using doxorubicin (DOX). Interleukin 1 has major role in DOX-induced nephrotoxicity, so we investigated the effect of interleukin 1 receptor antagonist diacerein (DIA) on DOX-induced nephrotoxicity. DIA (25 and 50 mg/kg/day) was administered orally to rats for 15 days, in the presence or absence of nephrotoxicity induced by a single intraperitoneal injection of DOX (15 mg/kg) at the 11th day. We measured levels of serum urea, creatinine, renal reduced glutathione (GSH), malondialdehyde (MDA), total nitrites (NOx), catalase, and superoxide dismutase (SOD). In addition, caspase-3, tumor necrosis factor alpha (TNFα), nuclear factor kappa B (NFκB) expressions, and renal histopathology were assessed. Our results showed that DOX-induced nephrotoxicity was ameliorated or reduced by both doses of DIA, but diacerein high dose (DHD) showed more improvement than diacerein low dose (DLD). This protective effect was manifested by significant improvement in all measured parameters compared to DOX treated group by using DHD. DLD showed significant improvement of creatinine, MDA, NOx, GSH, histopathology, and immunohistochemical parameters compared to DOX treated group.http://dx.doi.org/10.1155/2016/9507563
spellingShingle Marwa M. M. Refaie
Entesar F. Amin
Nashwa F. El-Tahawy
Aly M. Abdelrahman
Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
Journal of Toxicology
title Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
title_full Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
title_fullStr Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
title_full_unstemmed Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
title_short Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
title_sort possible protective effect of diacerein on doxorubicin induced nephrotoxicity in rats
url http://dx.doi.org/10.1155/2016/9507563
work_keys_str_mv AT marwammrefaie possibleprotectiveeffectofdiacereinondoxorubicininducednephrotoxicityinrats
AT entesarfamin possibleprotectiveeffectofdiacereinondoxorubicininducednephrotoxicityinrats
AT nashwafeltahawy possibleprotectiveeffectofdiacereinondoxorubicininducednephrotoxicityinrats
AT alymabdelrahman possibleprotectiveeffectofdiacereinondoxorubicininducednephrotoxicityinrats